chloroform has been researched along with imatinib mesylate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Musmade, P; Subramanian, G; Vadera, N | 1 |
1 other study(ies) available for chloroform and imatinib mesylate
Article | Year |
---|---|
Stability-indicating HPTLC determination of imatinib mesylate in bulk drug and pharmaceutical dosage form.
Topics: Antineoplastic Agents; Benzamides; Calibration; Capsules; Chloroform; Chromatography, Thin Layer; Densitometry; Drug Stability; Guidelines as Topic; Hydrolysis; Imatinib Mesylate; Linear Models; Methanol; Oxidation-Reduction; Piperazines; Powders; Protein Kinase Inhibitors; Pyrimidines; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Silica Gel; Silicon Dioxide; Solvents; Technology, Pharmaceutical; Temperature | 2007 |